Zusammenfassung
Das Trockene Auge ist eine der häufigsten Erkrankungen in der täglichen ophthalmologischen Praxis. In den letzten Jahren wurde eine Vielzahl neuer Erkenntnisse zur Pathogenese der Erkrankung gewonnen. Die Hyperosmolarität des Tränenfilms beim Trockenen Auge wird für die Entwicklung einer – häufig subklinischen – Entzündung der Augenoberfläche, der Tränendrüse und des Tränenfilms mitverantwortlich gemacht. Osmoprotektiva können mit Hilfe von kompatiblen Soluten die Oberflächenschädigung durch einen hyperosmolaren Tränenfilm theoretisch vermeiden.
Abstract
Dry eye syndrome is one of the most common disorders encountered in daily ophthalmological practice. New pathophysiological concepts have been developed over the last few years. Hyperosmolarity of the tear film is one of the key pathogenetic factors in the development of a – commonly subclinical – inflammation of the ocular surface, the lacrimal gland and the tear film in dry eye syndrome. Osmoprotective agents act through compatible solutes to prevent – at least in theory –a hyperosmolar tear film from damaging the ocular surface.
Literatur
2007 Report of the International Dry Eye Workshop (DEWS) (2007). Ocul Surf 5: 67–204
Alagoz G, Celiker U, Ilhan N et al. (2002) L-carnitine in experimental retinal ischemia-reperfusion injury. Ophthalmologica 216: 144–150
Baudouin C (2007) Un nouveau schéma pour mieux comprende les maladies de la surface oculaire. J Fr Ophthalmol 30: 239–246
Balik J (1952) The lacrimal gland fluid in keratoconjunctivitis sicca: a quantitative and qualitative investigation. Am J Ophthalmol 35: 773–782
Bron AJ, Tiffany JM, Yokoi N et al. (2002) Using osmolarity to diagnose dry eye: a compartmental hypothesis and review of our assumptions. Adv Exp Med Biol 506: 1087–1095
Farris RL (1985) Tear analysis in contact lens wearers. Trans Am Ophthalmol Soc 83: 501–545
Farris RL, Gilbard JP, Stuchell RN et al. (1983) Diagnostic tests in keratoconjunctivitis sicca. CLAO J 9: 23–28
Farris RL, Stuchell RN, Mandel ID (1981) Basal and reflex human tear analysis. I. Physical measurements. Osmolarity, basal volumes, and reflex flow rate. Ophthalmology 88: 852–857
Feher J, Kovacs B, Kovacs I et al. (2005) Improvement of visual functions and fundus alterations in early age-related macular degenerations treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 219: 154–166
Gegley CG (2007) The sensation problem. The biology and psychology of pain and irritation. Vortrag/Abstract: TFOS Meeting, Taormina, Italien, 2007
Geraldine P, Sneha BB, Elanchezhian R et al (2006) Prevention of selenite-induced cataractogenesis by acetyl-L-carnitine: an experimental study. Exp Eye Res 83: 1340–1349
Gilbard JP (1985) Tear film osmolarity and keratoconjunctivitis sicca. CLAO J 11: 243–250
Gilbard JP (1994) Human tear film electrolyte concentrations in health and dry eye disease. Int Ophthalmol Clin 34: 27–36
Gilbard JP, Carter JB, Sang DN et al. (1984) Morphologic effect of hyperosmolarity on rabbit corneal epithelium. Ophthalmology 91: 1205–1212
Gilbard JP, Dartt DA (1982) Changes in rabbit lacrimal gland fluid osmolarity with flow rate. Invest Ophthalmol Vis Sci 23: 804–806
Gilbard JP, Farris RL (1979) Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmol 97: 1642–1646
Gilbard JP, Farris RL (1983) Ocular surface drying and tear film osmolarity in thyroid eye disease. Acta Ophthalmol 61: 108–116
Gilbard JP, Farris RL, Santamaria J (1978) Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol 96: 677–681
Gilbard JP, Gray LK, Rossi SR (1986) A proposed mechanism for increased tear-film osmolarity in contact lens wearers. Am J Ophthalmol 102: 505–507
Gilbard JP, Rossi SR, Gray KL et al (1988) Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 29: 374–378
Kislan T, Rajesh R (2007) Evaluation of Optive in patiens previously using Systane for the treatment of dry eye signs and symptoms. Am Acad Optom, Scientific Meeting, 2007
Li DQ, Chen Z, Song XJ et al. (2004) Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci 45: 4302–4311
Li DQ, Luo L, Chen Z et al. (2006) JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α, and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 82: 588–596
Luo L, Li DQ, Corrales RM et al. (2005) Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 31: 186–193
Mastman GJ, Baldes EJ, Henderson JW (1961) The total osmotic pressure of tears in normal and various pathologic conditions. Arch Ophthalmol 65: 509–513
Mishima S, Kubota Z, Farris RL (1971). The tear flow dynamics in normal and in keratoconjunctivitis sicca cases. In: Solanes MP (ed) Ophthalmology. Proceedings of the XXI. International Congress, Mexiko. Excerpta Medica, Amsterdam, pp 1801–1805
Nelson JD, Wright JC (1984) Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 102: 1049–1051
Pessotto P, Valeri P, Arrigoni-Martelli E (1994) The presence of L-carnitine in ocular tissues of the rabbit. J Ocul Pharmacol 10: 643–651
Rolando M, Refojo MF, Kenyon KR (1983) Increased tear film evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 101: 557–558
Scherz W, Doane MG, Dohlman CH (1974) Tear volume in normal eyes and keratoconjunctivitis sicca. Graefes Arch Clin Exp Ophthalmol 192: 141–150
Shamsi FA, Chaudhry IA, Boulton ME et al. (2007) L-carnitine protects human retinal pigment epithelial cells from oxidative damage. Curr Eye Res 32: 575–584
Simmons P, Vehige J, Chang-Lin JE et al. (2007) Use of compatible solutes to protect the ocular surface from hyperosmolar stress. (submitted)
Stern ME, Pflugfelder SC (2004) Inflammation in dry eye. Ocul Surf 2: 124–130
Tomlinson A, Khanal S, Ramaesh K et al. (2006) Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 47: 4309–4315
Verges C, Refojo MF, Gilbard JP et al. (1984) Effect of hyperosmolarity on conjunctival goblet cell density in vivo. Invest Ophthalmol Vis Sci 25 (S): 191
Von Bahr G (1941) Könnte der Flüssigkeitsabgang durch die Cornea von physiologischer Bedeutung sein? Acta Ophthalmol 19: 125–134
Yeh S, Song XJ, Farley W et al. (2003) Apoptosis of ocular surface cells in experimental induced dry eye. Invest Ophthalmol Vis Sci 44: 124–129
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehung/en hin: Beratungs- und Referententätigkeit für Fa. Allergan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Messmer, E. Osmoprotektion als therapeutisches Prinzip. Ophthalmologe 104, 987–990 (2007). https://doi.org/10.1007/s00347-007-1649-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-007-1649-z